Bryan, Garnier & Co's News

AstraZeneca: Despite worrying briefing documents, lesinurad gets positive recommendation from AdCom

BUY, Fair Value  5100p (+25%)
News published on
October Monday 26, 2015


For more information, please contact marketing@bryangarnier.com